Anti- Glaucoma

Composition: Travoprost IP 0.04 mg

Indications:

• Reduction of elevated intraocular pressurein patients with open-angle glaucoma or ocular hypertension

Description:

• Low rates of topical and systemic adverse reactions, strong ocular hypotensive efficacy, and once-a-day dosing make travoprost a first-line treatment for patients affected with elevated IOP.
• Exerts its ocular hypotensive action mainly by increasing uveoscleral outflow, but some effects on trabecular meshwork may be present as well
• Provides sustained IOP reduction throughout the 24-hour dosing interval in subjects with ocular hypertension or open-angle glaucoma.
• superior to timolol in lowering IOP in patients with POAG (Primary Open Angle Glaucoma)

Presentation- 10 ml

Dosage Form: Eye Drop

How to Use: As directed by physician

Composition: Brimonidine Tartrate 0.2 % w/v, Stabilized Oxychloro Complex 0.005% w/v

Indications:

• Glaucoma
• Ocular Hypertension

Description:

• Effectively reduced Intra Ocular Pressure
• It is used safely and reliably to reduce IOP in glaucoma and OHT.
• It may also reduce the risk of glaucomatous progression.

Presentation: 5 ml

Dosage Form: Eye Drop

How to Use: As directed by physician

Composition: Brimonidine Tartrate 0.2 % w/v, Timolol Maleate 0.5% w/v

  Indications:

• Glaucoma
• Ocular Hypertension

 Description:

 Provided greater IOP-lowering efficacy than 0.5% timolol

• An efficacious & safe therapy with alpha-agonist & beta blocker.
• 2% brimonidine 3 times daily used as monotherapy.

Presentation: 5 ml

Dosage Form: Eye Drop

How to Use: As directed by physician

Composition– Timolol Maleate 0.5 w/v

Indications– Open Angle Glaucoma, Ocular Hypertension, Normal Tension Glaucoma

• First line therapy in elevated IOP (Intra Ocular Pressure).
• Timolol monotherapy offers lower cost of care over 5 years compared to prostaglandin analogues.

Presentation- 5 ml